Filing Details
- Accession Number:
- 0001628280-24-051264
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-13 19:12:16
- Reporting Period:
- 2024-12-13
- Accepted Time:
- 2024-12-13 19:12:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1386570 | Chromadex Corp. | CDXC | Medicinal Chemicals & Botanical Products (2833) | 262940963 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437237 | Jr L Frank Jaksch | 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-12-13 | 50,001 | $3.66 | 281,340 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-12-13 | 37,161 | $6.19 | 244,179 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (right to buy) | Disposition | 2024-12-13 | 50,001 | $0.00 | 50,001 | $3.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-07-06 | 2025-07-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,075,052 | Indirect | By Black Sheep, FLP |
Footnotes
- The sale of shares was solely to cover the exercise cost and associated taxes for the exercise of the options which were scheduled to expire on July 5, 2025. As a result of the exercise of the options, the Reporting Person will own 12,840 more shares.
- The weighted average sale price for the transaction reported was $6.1881, and the range of prices were between $6.13 and $6.285. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- Held by Black Sheep, FLP, a California limited partnership, of which the Reporting Person and Tricia A. Jaksch are the sole co-general partners and the Reporting Person, Tricia A. Jaksch and certain trusts for the benefit of the Reporting Person's family are the sole limited partners. The Reporting Person disclaims beneficial ownership of the shares held by the limited partnership, except to the extent of any pecuniary interest therein.